Last Updated: November 9, 2026

CLINICAL TRIALS PROFILE FOR ZAVESCA

« Back to Dashboard

All Clinical Trials for ZAVESCA

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00319046 ↗	Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease	Completed	Actelion	Phase 3	2006-02-01	Although miglustat has been approved as a treatment for mild to moderate type 1 Gaucher disease in patients who are unsuitable for enzyme replacement therapy (ERT), more data are required to establish the long term efficacy, safety and tolerability of miglustat in maintaining diseases stability after a switch from ERT.
NCT00418847 ↗	Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis	Completed	Actelion	Phase 2	2004-07-01	The purpose of the study is to investigate the pharmacokinetics of Zavesca (miglustat, OGT918) when given as single and multiple doses in juvenile patients with GM2 gangliosidosis.
NCT00418847 ↗	Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis	Completed	The Hospital for Sick Children	Phase 2	2004-07-01	The purpose of the study is to investigate the pharmacokinetics of Zavesca (miglustat, OGT918) when given as single and multiple doses in juvenile patients with GM2 gangliosidosis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ZAVESCA

Condition Name

Chart
Table

Condition Name for ZAVESCA
Intervention	Trials
Pompe Disease	2
Niemann-Pick Disease Type C	1
Niemann-Pick Disease, Type C	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ZAVESCA
Intervention	Trials
Gangliosidoses	3
Niemann-Pick Diseases	3
Niemann-Pick Disease, Type C	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ZAVESCA

Trials by Country

Map
Table

Trials by Country for ZAVESCA
Location	Trials
United States	10
Taiwan	3
Canada	3
Iran, Islamic Republic of	3
Spain	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ZAVESCA
Location	Trials
Florida	2
New York	2
District of Columbia	2
Wisconsin	1
Oregon	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ZAVESCA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ZAVESCA
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	4
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ZAVESCA
Clinical Trial Phase	Trials
Completed	7
Terminated	2
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ZAVESCA

Sponsor Name

Chart
Table

Sponsor Name for ZAVESCA
Sponsor	Trials
Actelion	8
University of Florida	2
National Taiwan University Hospital	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ZAVESCA
Sponsor	Trials
Other	10
Industry	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.